Pfizer, of course, will make a killing. According to the Wall Street Journal’s Market Watch, “Pfizer could potentially earn approximately $36 billion in sales resulting from an unprecedented Bill & Melinda Gates Foundation (BMGF) investment—$560 million from BMGF, totaling $4.3 billion with government contributions—that promotes Depo-Provera as the optimum contraceptive for women of color and low-income women.”91
